Enhanced psychosocial well-being following participation in a mindfulness-based stress reduction program is associated with increased natural killer cell activity.
BACKGROUND
Mindfulness-based stress reduction (MBSR) programs have consistently been shown to enhance the psychosocial well-being of participants. Given the well-established association between psychosocial factors and immunologic functioning, it has been hypothesized that enhanced psychosocial well-being among MBSR participants would be associated with corresponding changes in markers of immune activity.


OBJECTIVE
The objectives of this study were to examine changes in psychosocial and immunologic measures in a heterogeneous patient sample following participation in a MBSR program.


METHODS
A single-group, pretest/post-test design was utilized.


METHODS
The intervention was conducted at an academic health center.


METHODS
This pilot study involved 24 participants (aged 28-72 years). Inclusion criteria were as follows: > or =18 years of age, English-speaking, and no known autoimmune disorder.


METHODS
The intervention was an 8-week MBSR program.


METHODS
Distress and quality of life (QOL) measures included the Brief Symptom Inventory-18 and the Medical Outcomes Survey Short-Form Health Survey, respectively. Immunologic measures included natural killer (NK) cell cytolytic activity and C-reactive protein (CRP).


RESULTS
Patients completed psychosocial assessments and provided a blood sample at baseline (pre-MBSR) and within 2 weeks post-MBSR. Significant improvements in anxiety and overall distress as well as across multiple domains of QOL were observed from baseline to post-MBSR. Reductions in anxiety and overall distress were associated with reductions in CRP. Patients who reported improvement in overall mental well-being also showed increased NK cytolytic activity from pre- to post-MBSR, whereas patients who reported no improvement in mental well-being showed no change in NK cytolytic activity.


CONCLUSIONS
Positive improvement in psychologic well-being following MBSR was associated with increased NK cytolytic activity and decreased levels of CRP.
Fang
Carolyn Y
CY
Fox Chase Cancer Center, Cheltenham, PA 19012, USA. carolyn.fang@fccc.edu
Reibel
Diane K
DK
Longacre
Margaret L
ML
Rosenzweig
Steven
S
Campbell
Donald E
DE
Douglas
Steven D
SD
D000328:Adult; D000368:Aged; D001007:Anxiety / Q000517:prevention & control; D002097:C-Reactive Protein / Q000378:metabolism*; D005260:Female; D006306:Health Surveys; D006801:Humans; D007694:Killer Cells, Natural / Q000378:metabolism*; D008297:Male; D019122:Meditation / Q000523:psychology; D008603:Mental Health; D008875:Middle Aged; D010865:Pilot Projects; D011603:Psychophysiology; D011788:Quality of Life; D013315:Stress, Psychological / Q000276:immunology* / Q000628:therapy
D002097:C-Reactive Protein
Oncol Nurs Forum. 2007 Sep;34(5):1059-66
17878133
Circulation. 1998 Sep 1;98(9):839-44
9738637
J Exp Ther Oncol. 1996 Nov;1(6):354-60
9414425
AIDS Res Hum Retroviruses. 2003 May;19(5):399-408
12803998
Brain Behav Immun. 1999 Mar;13(1):61-72
10371678
J Altern Complement Med. 2003 Oct;9(5):683-94
14629846
ANS Adv Nurs Sci. 2005 Oct-Dec;28(4):320-32
16292018
JAMA. 1999 Jun 23-30;281(24):2268-70
10386538
Ann Oncol. 2002;13 Suppl 4:165-9
12401684
Psychoneuroendocrinology. 2004 May;29(4):448-74
14749092
J Altern Complement Med. 2002 Dec;8(6):719-30; discussion 731-5
12614525
J Behav Med. 2001 Aug;24(4):323-39
11523331
AIDS Res Hum Retroviruses. 2001 Apr 10;17(6):543-52
11350668
Diabetes. 2002 May;51(5):1596-600
11978661
Cancer. 1995 Apr 15;75(8):2077-82
7535184
Psychosom Med. 2003 Jul-Aug;65(4):571-81
12883107
J Natl Cancer Inst. 1998 Jan 7;90(1):30-6
9428780
Brain Behav Immun. 2007 Oct;21(7):901-12
17475444
N Engl J Med. 1994 Aug 18;331(7):417-24
7880233
J Consult Clin Psychol. 2002 Jun;70(3):537-47
12090368
Brain Behav Immun. 2003 Feb;17 Suppl 1:S27-36
12615183
Neuroimmunomodulation. 2000;8(3):154-64
11124582
Am J Psychiatry. 2005 Nov;162(11):2125-30
16263853
Nat Rev Immunol. 2005 Mar;5(3):243-51
15738954
Psychosom Med. 1993 Sep-Oct;55(5):395-409
8265740
Brain Behav Immun. 2007 Feb;21(2):185-94
16908118
Psychooncology. 2009 Jun;18(6):571-9
19023879
J Immunol Methods. 1992 Jan 21;146(1):91-103
1735786
Med Care. 1992 Jun;30(6):473-83
1593914
J Altern Complement Med. 2008 Apr;14(3):251-8
18370583
Atherosclerosis. 2006 Apr;185(2):320-6
16005881
Gen Hosp Psychiatry. 1982 Apr;4(1):33-47
7042457
Brain Behav Immun. 2008 Aug;22(6):969-81
18359186
J Psychosom Res. 2004 Jul;57(1):35-43
15256293
Int J Behav Med. 2005;12(4):278-85
16262547
Gen Hosp Psychiatry. 2001 Jul-Aug;23(4):183-92
11543844
J Psychosom Res. 2008 Apr;64(4):393-403
18374738
Clin Sci (Lond). 2001 Aug;101(2):185-92
11473494
Br J Cancer. 2002 Jul 29;87(3):264-7
12177792
J Immunol. 1995 May 15;154(10):5511-27
7730652
J Immunol. 1996 Aug 15;157(4):1638-44
8759750